AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

A big failure for Nabi.(BIOSCIENCES)

South Florida CEO

| November 01, 2005 | Broder-Singer, Rochelle | COPYRIGHT 2005 CEO Publishing Group, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Vaccine developer Nabi Biopharmaceuticals suffered a major blow this month when a vaccine it developed to ward off staphylococcus infections, known as staph, failed to do so in its Phase III clinical trial. The Boca Raton-based company said in a press release that the majority of its development dollars this year have been spent on the vaccine, called StaphVAX, and a related product. Nabi also said it is immediately halting development, and will try to figure out why a ...

Related articles from newspapers, magazines, journals, and more
Product Supply Issues Expected To Impact Nabi's Q3 Pharmaceutical Results;...
Press release article from: PR Newswire September 19, 2000 700+ words
...products we market." Nabi is in the process of...manufactured at this facility, Nabi-HB, by the end of...preliminary results from the Phase III clinical trial of StaphVAX...and the results of the Phase III clinical trial is scheduled...company's website. Nabi, a fully ...
Nabi Biopharmaceuticals Acquires Exclusive North American Commercialization...
Press release article from: PR Newswire April 3, 2006 700+ words
...in exchange for a royalty. Nabi Biopharmaceuticals will be responsible...agreement with Fresenius Biotech, Nabi Biopharmaceuticals will assume...blind, placebo-controlled Phase III clinical study that is being...clinical milestones are met, Nabi Biopharmaceuticals expects to...
ICAAC NABI STOCK DROPS 40% FOLLOWING STAPHVAX PHASE III TRIAL RESULTS.
Magazine article from: BIOWORLD Today Osborne, Randall September 20, 2000 700+ words
...double-whammy of bad news for Nabi - early data from a Phase III trial of its product against...company's stock (NASDAQ:NABI) tumbling more than 40 percent...blinded, placebo-controlled Phase III trial of Nabi's Staphylococcus aureus...
Nabi acquires exclusive rights to Phase III organ transplantation rejection...
Newspaper article from: BIOTECH Patent News March 1, 2006 700+ words
...in exchange for a royalty. Nabi Biopharmaceuticals will be responsible...agreement with Fresenius Biotech, Nabi Biopharmaceuticals will assume...blind, placebo-controlled Phase III clinical study that is being...clinical milestones are met, Nabi Biopharmaceuticals expects to...
Nabi Biopharmaceuticals Successfully Completes StaphVAX(R) Immunogenicity...
Press release article from: PR Newswire September 8, 2003 700+ words
Nabi Biopharmaceuticals today announced...for use in a confirmatory Phase III trial later this year. The...plant and used in our previous Phase III clinical trial," said Henrik...000 patient confirmatory Phase III trial and we remain on track...
Seeking Confirmation, Nabi Starts StaphVAX Phase III Renal Study.(Nabi...
Magazine article from: BIOWORLD Today Osborne, Randall September 30, 2003 700+ words
...Using lessons learned from the first Phase III trial of StaphVAX, Nabi Biopharmaceuticals Inc. started the second Phase III study - intended to be pivotal - with...relations for Rockville, Md.-based Nabi. About 3,000 patients on hemodialysis...
NABI SEES POSITIVE RESULTS IN PHASE III OF STAPHVAX.
Magazine article from: BIOWORLD Today Seachrist, Lisa August 26, 1999 700+ words
...pivotal trial testingthe ability of the Nabi-StaphVAX vaccine toprevent gram...new drugapplication with the FDA. Nabi, of Boca Raton, Fla., is testing a singledose of Nabi-StaphVAX in a Phase III trialagainst a placebo injection in...
Nabi Biopharmaceuticals Announces Results of StaphVAX(R) Confirmatory Phase III...
Press release article from: PR Newswire November 1, 2005 700+ words
...PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals today...company's confirmatory Phase III clinical trial. The...immunogenic, confirming that Nabi Biopharmaceuticals...chief executive officer, Nabi Biopharmaceuticals...StaphVAX confirmatory Phase III trial. While we complete...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA